FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| CELLTECH | Celltech Chiroscience Limited | 216 Bath Road Slough, Berkshire, SL1 4EN United Kingdom | Pharmaceutical preparations and gene therapy products, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodialators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations, muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for use in chemotherapy, vaccines;Inhalers for therapeutic use;Research and development services; consultancy services; all relating to the biological, medical and chemical sciences;The color of the design is displayed in blue.; |
| CELLTECH | Celltech Chiroscience Limited | 216 Bath Road Slough, Berkshire, SL1 4EN United Kingdom | Pharmaceutical preparations and gene therapy products, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodialators, cardivascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraines treatment preparations, muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for use in chemotherapy, vaccines;Inhalers for therapeutic use;research and development services; consultancy services; all relating to the biological, medical and chemical sciences; |
| CELLTECH PHARMA | Celltech Chiroscience Limited | 216 Bath Road Slough, Berkshire, SL1 4EN United Kingdom | Pharmaceutical preparations and gene therapy products, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodialators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations, muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for use in chemotherapy, vaccines;Inhalers for therapeutic use;research and development services; consultancy services; all relating to the biological, medical and chemical sciences; |
| CELLTECH R&D | Celltech Chiroscience Limited | 216 Bath Road Slough, Berkshire, SL1 4EN United Kingdom | Pharmaceutical preparations and gene therapy products, namely allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodialators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, hemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations, muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for us in chemotherapy, vaccines;Inhalers for therapeutic use;R&D;Research and development services; consultancy services; all relating to the biological, medical and chemical sciences; |
| CRISPR-GNDM | Modalis Therapeutics Corporation | 3-11-5, Nihonbashi-Honcho, Japan | Pharmaceutical preparations for gene therapy; reagent paper for medical purposes;CRISPR GUIDE NUCLEOTIDE DIRECTED MODULATION;Reagents for research purposes;Providing medical information; physical examination;Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; |
|
|
|||
| ENDLESS | Laronde, Inc. | 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; |
| ENDLESS RNA | Laronde, Inc. | 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders;RNA;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; |
| ERNA | Laronde, Inc. | 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; |
| GENERIDE | LogicBio Therapeutics, Inc. | 65 Hayden Ave. Lexington MA 02421 | Pharmaceutical preparations for gene therapy and gene editing;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; |
| GENREPLA | AVEXIS, INC. | 2275 Half Day Rd., Suite 200 Bannockburn IL 60015 | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression; |
| KRIYA | Kriya Therapeutics, Inc | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases;Biological preparations for use in industry and science;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA CHRONIC DISEASE | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;CHRONIC DISEASE;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA GENE THERAPY | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases;Biological preparations for use in industry and science;GENE THERAPY;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA MANUFACTURING | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases;Biological preparations for use in industry and science;MANUFACTURING;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA ONCOLOGY | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;ONCOLOGY;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA RARE DISEASE | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;RARE DISEASE;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA RESEARCH AND DEVELOPMENT | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases;Biological preparations for use in industry and science;RESEARCH AND DEVELOPMENT;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| KRIYA TECHNOLOGY | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases;Biological preparations for use in industry and science;TECHNOLOGY;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| LOGICBIO | LogicBio Therapeutics, Inc. | 65 Hayden Ave. Lexington MA 02421 | Pharmaceutical preparations for gene therapy and gene editing;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; |
| LOGICBIO | LogicBio Therapeutics, Inc. | 65 Hayden Ave. Lexington MA 02421 | Pharmaceutical preparations for gene therapy and gene editing;LOGIC BIO;Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; |
| MODALIS | Modalis Therapeutics Corporation | 3-11-5, Nihonbashi-Honcho, Japan | Pharmaceutical preparations for gene therapy; reagent paper for medical purposes;Reagents for research purposes;Providing medical information; physical examination;Testing, inspection or research services in the fields of pharmaceuticals, cosmetics or foodstuffs; |
| NOVISMA | AVEXIS, INC. | 2275 Half Day Rd., Suite 200 Bannockburn IL 60015 | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression; |
| ONGENSMA | AVEXIS, INC. | 2275 Half Day Rd., Suite 200 Bannockburn IL 60015 | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression; |
| ONREPLA | AVEXIS, INC. | 2275 Half Day Rd., Suite 200 Bannockburn IL 60015 | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression; |
| SAAVY | LogicBio Therapeutics, Inc. | 65 Hayden Ave. Lexington MA 02421 | Pharmaceutical preparations for gene therapy and gene editing; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy; biotechnological platform technology, namely, biological nanoparticles for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; drug delivery agents consisting of compounds comprised of proteins in the form of capsids and particles that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents, in the form of injectable solutions, intravenous fluids, intracerebral solutions, intrathecal solutions, intracisternal solutions, intraocular solutions, intranasal solutions, intratracheal solutions, intraarterial solutions, intramuscular solutions, and medicinal infusions in that facilitate the delivery of capsids and particles used for delivery of gene therapy;SAVVY;medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that feature adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; |
| SIRVE | Kriya Therapeutics, Inc. | 1100 Island Drive, Suite 203 Redwood City CA 94065 | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;Biological and biochemical preparations for use in industry and science;The English translation of the word SIRVE in the mark is he, she, it serves.;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; |
| SKYLARK | Skylark Bio, Inc. | 325 Vassar Street, Suite 2A Cambridge MA 02139 | Pharmaceutical preparations and gene therapy pharmaceutical preparations for the treatment of sensory impairments, disorders and/or conditions;Pharmaceutical and gene therapy delivery devices, namely, syringes, catheters, microneedles, pumps, mini-pumps, micro-pumps, probes, micro perforators and cochleostomy connectors; |
| SYMBIGENE | Symbigene, Inc. | 2701 Loker Avenue West Suite 150 Carlsbad CA 92008 | Pharmaceutical preparations for gene therapy, vaccines, infectious diseases and cancer; |
| ZOLGENSMA | NOVARTIS AG | CH-4002 Basel 4002 Switzerland | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression; |
Where the owner name is not linked, that owner no longer owns the brand |
|||